Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-27

Clinical Trial Update: Lucentis in Advanced Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial of Lucentis for advanced age-related macular degeneration completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lucentis (ranibizumab)

Snippet

Sponsor: Steven R. Sanislo | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2015-05-27